Nervorum Biotechnologies Inc.

Indalarium

A novel indanyl-propargylamine featuring an indane core with an N-propargyl substituent. This compound shows strong potential as a CNS-active MAO inhibitor with favorable physicochemical and pharmacokinetic properties.

Molecule Structure

Overview & Identification

IUPAC

[1-(2,3-dihydro-1H-inden-1-yl)ethyl](prop-2-yn-1-yl)amine

Formula

C14H17N

Molecular Weight

199.30 g/mol

Exact Molecular Weight

199.1361

Composition

C: 84.37%, H: 8.60%, N: 7.03%

CAS Number

Not assigned (novel compound)

Physical & Chemical Properties

Intrinsic Solubility (logS)

-3.13

logP

2.88

logD (pH 7.4)

1.08

Most Basic pKa

9.21

Hydrogen Bond Donors

1

Hydrogen Bond Acceptors

1

Rotatable Bonds

4

Topological Polar Surface Area (TPSA)

≈ 12 Ų

SMILES

CC(C1c2ccccc2CC1)NCC#C

pH-Dependent Properties

Solubility (Log S)

Lipophilicity (Log D)

Predicted solubility and lipophilicity profiles suggest balanced amphiphilicity—low aqueous solubility but suitable membrane permeability for CNS penetration.

Synthesis Overview

Method 1

Reductive amination of 1-(2,3-dihydro-1H-inden-1-yl)ethanone with propargylamine, followed by reduction with NaBH₃CN.

Method 2

Reaction of 1-(2,3-dihydro-1H-inden-1-yl)ethan-1-amine with propargyl bromide in the presence of base (e.g. Na₂CO₃) in acetonitrile.

Applications & Uses

Research Use

MAO inhibition studies, neuroprotective agent screening, and CNS pharmacokinetics research.

Therapeutic Potential

Investigational use for Parkinson’s disease, depression, ADHD, and related neuropsychiatric disorders.

Pharmaceutical Utility

Prototype scaffold for propargylamine-based MAO inhibitors; potential salt forms include HCl, mesylate, and fumarate.

References